Jinyu Bio-technology Co., Ltd. (SHA:600201)

China · Delayed Price · Currency is CNY

11.77

-0.13 (-1.09%)

Jun 18, 2026, 3:00 PM CST

54.06% (1Y)

Market Cap	12.86B +62.6%
Revenue (ttm)	1.39B +10.5%
Net Income	104.27M +30.5%
EPS	0.09 +27.3%
Shares Out	1.09B
PE Ratio	127.24
Forward PE	49.79
Dividend	0.04 (0.31%)
Ex-Dividend Date	Jun 26, 2025

Volume	14,325,695
Open	11.90
Previous Close	11.90
Day's Range	11.76 - 12.00
52-Week Range	7.22 - 19.00
Beta	0.65
Analysts	Strong Buy
Price Target	16.57 (+40.78%)
Earnings Date	Aug 24, 2026

About Jinyu Bio-technology

Jinyu Bio-technology Co., Ltd. manufacturing and sales of veterinary biological drugs in China. The company operates through three segments, such as veterinary biological products, veterinary chemical drugs, and traditional Chinese veterinary medicines. The company offers various pig vaccines, including combined porcine circovirus type 2 and mycoplasma pneumoniae, classical swine fever, combined transmissible gastroenteritis and porcine epidemic diarrhea, swine influenza bivalent, porcine reproductive and respiratory syndrome, pseudorabies ther... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1992

Employees 1,881

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600201

Full Company Profile

Financial Performance

In 2025, Jinyu Bio-technology's revenue was 1.40 billion, an increase of 11.23% compared to the previous year's 1.26 billion. Earnings were 100.11 million, a decrease of -8.14%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 600201 stock is "Strong Buy." The 12-month stock price target is ¥16.57, which is an increase of 40.78% from the latest price.

Price Target

¥16.57

(40.78% upside)

Analyst Consensus: Strong Buy

Stock Forecasts